Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-08 Sale | 2025-05-12 4:00 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 337,915 | $18.04 | $6,097,304 | 150,996 (Direct) | View |
| 2025-03-05 Sale | 2025-03-07 4:05 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 70,961 | $15.91 | $1,128,642 | 117,566 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:19 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 6,181 | $15.8 | $97,639 | 119,768 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:16 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer | 4,827 | $15.8 | $76,250 | 62,137 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:11 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 23,251 | $15.8 | $367,288 | 69,754 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 140,372 | $15.8 | $2,217,407 | 191,665 (Direct) | View |
| 2025-03-04 Sale | 2025-03-06 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 23,773 | $15.8 | $375,534 | 422,452 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:12 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 62,250 | $16.06 | $999,425 | 124,503 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:08 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 24,900 | $16.06 | $399,770 | 49,801 (Direct) | View |
| 2025-03-03 Sale | 2025-03-05 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 31,342 | $16.06 | $503,236 | 379,795 (Direct) | View |
| 2025-02-28 Sale | 2025-03-04 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 55,750 | $16.21 | $903,462 | 297,343 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 75,506 | $16.95 | $1,279,661 | 371,100 (Direct) | View |
| 2025-02-12 Sale | 2025-02-14 4:03 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 177,626 | $16.25 | $2,886,565 | 204,964 (Direct) | View |
| 2024-12-20 Sale | 2024-12-26 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | MIGNONE ROBERTO Director | 286,000 | $22.01 | $6,294,031 | 790,683 (Indirect Direct) | View |
| 2024-11-20 Sale | 2024-11-21 4:04 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 19,388 | $16.87 | $327,085 | 234,580 (Direct) | View |
| 2024-08-12 Sale | 2024-08-13 4:09 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 98,943 | $17.3 | $1,711,447 | 0 (Direct) | View |
| 2024-08-09 Sale | 2024-08-13 4:06 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Grant Angus EVP, Business Development | 4,065 | $17.28 | $70,243 | 47,587 (Direct) | View |
| 2024-08-09 Sale | 2024-08-13 4:02 pm | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 45,060 | $17.38 | $782,972 | 0 (Direct) | View |
| 2024-08-01 Sale | 2024-08-05 07:35 am | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 24,537 | $17.25 | $423,280 | 150,546 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-05 Option Award | 2025-03-07 4:29 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 14,150 | $0 | 44,400 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:29 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 3,566 | $0 | 44,400 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:25 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 71,278 | $0 | 71,278 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:22 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer | 56,603 | $0 | 56,603 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 79,664 | $0 | 538,727 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 21,390 | $0 | 538,727 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 78,616 | $0 | 78,616 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 62,893 | $0 | 551,804 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 23,765 | $0 | 551,804 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:10 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shields Matthew EVP, Global Operations | 69,182 | $0 | 69,182 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Jover Placid See "Remarks" | 56,603 | $0 | 56,603 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 69,182 | $0 | 117,566 (Direct) | View |
| 2025-03-05 Exercise | 2025-03-07 4:05 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 22,576 | $0 | 117,566 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 169,811 | $0 | 169,811 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:21 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 16,326 | $0 | 54,313 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:19 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 20,461 | $0 | 119,768 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | McAvoy David R. EVP, Chief Legal Officer | 16,741 | $0 | 62,137 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:13 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 239,932 | $0 | 540,939 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:11 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 23,251 | $0 | 69,754 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 235,282 | $0 | 554,461 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 237,142 | $0 | 191,665 (Direct) | View |
| 2025-03-04 Exercise | 2025-03-06 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 50,223 | $0 | 422,452 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:20 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Weiss Amir Chief Accounting Officer | 5,179 | $0 | 20,717 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:16 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark See "Remarks" | 24,900 | $0 | 279,665 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:12 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 62,250 | $0 | 124,503 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:08 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 24,900 | $0 | 49,801 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 67,231 | $0 | 379,795 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-04 4:02 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 49,800 | $0 | 297,343 (Direct) | View |
| 2025-02-15 Exercise | 2025-02-19 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Francis Richard D President and CEO | 161,655 | $0 | 371,100 (Direct) | View |
| 2025-01-28 Option Award | 2025-01-30 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Daniell Richard Exec. VP, European Commercial | 183,169 | $0 | 183,169 (Direct) | View |
| 2025-01-28 Option Award | 2025-01-30 4:03 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Sabag Mark EVP, International Markets | 183,169 | $0 | 183,169 (Direct) | View |
| 2025-01-28 Option Award | 2025-01-30 4:01 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Kalif Eliyahu Sharon EVP, Chief Financial Officer | 183,169 | $0 | 183,169 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-04 4:07 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Lichtenstein Chen Director | 4,804 | $0 | 4,804 (Direct) | View |
| 2024-11-20 Exercise | 2024-11-21 4:04 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Fox Christine EVP, Head of U.S. Commercial | 63,492 | $0 | 234,580 (Direct) | View |
| 2024-09-02 Exercise | 2024-09-04 07:40 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Shalev Varda Director | 12,872 | $0 | 12,872 (Direct) | View |
| 2024-08-09 Exercise | 2024-08-13 4:06 pm | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Grant Angus EVP, Business Development | 12,913 | $0 | 47,587 (Direct) | View |
| 2024-08-01 Exercise | 2024-08-05 07:35 am | N/A N/A | TEVA PHARMACEUTICAL INDUSTRIES LTD | TEVA | Hughes Eric A See "Remarks" | 52,742 | $0 | 150,546 (Direct) | View |